This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ostberg, J. E. Articles by Conway, G. S. Search for Related Content PubMed PubMed Citation Articles by Ostberg, J. E. Articles by Conway, G. S.

A Comparison of Echocardiography and Magnetic Resonance Imaging in Cardiovascular Screening of Adults with Turner Syndrome

Departments of Endocrinology (J.E.O., C.M., G.S.C.), Imaging (J.A.S.B.), and Cardiology (J.H.), University College London Hospitals, London, United Kingdom W1T 3AA

Address all correspondence and requests for reprints to: Dr. Gerard Conway, Department of Endocrinology, The Middlesex Hospital, London, United Kingdom W1T 3AA. E-mail g.conway{at}ucl.ac.uk.

The high mortality rate from aortic dissection of women with Turner syndrome (TS) achieving ovum donation pregnancies has highlighted the need for a refinement of cardiac screening protocols. Echocardiography and magnetic resonance imaging (MRI) are used to assess the risk factors, aortic root dilatation, bicuspid aortic valve, and coarctation, but the relative merits of each modality are unclear. Cardiovascular screening was performed in 128 unselected women with TS (mean age ± SD, 31.1 ± 8.5 yr) using echocardiography (n = 120) and MRI (n = 115) and in 36 age-matched normal control women. Clinical history, anthropometric measurements, blood pressure, and metabolic parameters were recorded. Echocardiography was normal in 53% of women with TS; MRI was normal in 34%. Aortic root dilatation was identified in 16% of women by echocardiography, 33% on MRI criteria, and 7% by both modalities. Height-adjusted echocardiographic aortic root dimensions were greater in TS than controls (2.90 vs. 2.62 cm; P = 0.010). Bicuspid aortic valve and increasing age were associated with greater aortic dimensions; the latter effect was more marked in TS than controls. On MRI, ascending aortic diameter was greater in TS than control women (2.83 vs. 2.52 cm; P = 0.029), but descending aortic diameter and ascending/descending aortic ratio were not, because these may be affected by the presence of coarctation. The two techniques are complementary and identify different aspects of cardiovascular pathology. Ascending/descending ratio on MRI circumvents issues of stature, but may be influenced by descending aortic abnormalities. We present reference ranges for absolute aortic dimensions in a TS population to aid future interpretation of these measurements.

This article has been cited by other articles:

				M. Devernay, E. Ecosse, J. Coste, and J.-C. Carel Determinants of Medical Care for Young Women with Turner Syndrome J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3408 - 3413. [Abstract] [Full Text] [PDF]

				B. E. Hjerrild, K. H. Mortensen, and C. H. Gravholt Turner syndrome and clinical treatment Br. Med. Bull., June 1, 2008; 86(1): 77 - 93. [Abstract] [Full Text] [PDF]

				L. Lopez, K. L. Arheart, S. D. Colan, N. S. Stein, G. Lopez-Mitnik, A. E. Lin, M. D. Reller, R. Ventura, and M. Silberbach Turner Syndrome Is an Independent Risk Factor for Aortic Dilation in the Young Pediatrics, June 1, 2008; 121(6): e1622 - e1627. [Abstract] [Full Text] [PDF]

				V. Sachdev, L. A. Matura, S. Sidenko, V. B. Ho, A. E. Arai, D. R. Rosing, and C. A. Bondy Aortic Valve Disease in Turner Syndrome J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1904 - 1909. [Abstract] [Full Text] [PDF]

				L. A. Matura, V. B. Ho, D. R. Rosing, and C. A. Bondy Aortic Dilatation and Dissection in Turner Syndrome Circulation, October 9, 2007; 116(15): 1663 - 1670. [Abstract] [Full Text] [PDF]

				C. A. Bondy and for The Turner Syndrome Consensus Study Group Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 10 - 25. [Abstract] [Full Text] [PDF]

				C. Bondy, V. K. Bakalov, E. D. Lange, and I. Ceniceros Deficient Medical Care for Adults with the Turner Syndrome Ann Intern Med, December 5, 2006; 145(11): 866 - 867. [Full Text] [PDF]

				N H Andersen, B E Hjerrild, K Sorensen, E M Pedersen, K Stochholm, L C Gormsen, A Horlyck, J S Christiansen, and C H Gravholt Subclinical left ventricular dysfunction in normotensive women with Turner's syndrome. Heart, October 1, 2006; 92(10): 1516 - 1517. [Full Text] [PDF]

				M D C Donaldson, E J Gault, K W Tan, and D B Dunger Optimising management in Turner syndrome: from infancy to adult transfer Arch. Dis. Child., June 1, 2006; 91(6): 513 - 520. [Abstract] [Full Text] [PDF]

				C. A. Bondy, P. L. Van, V. K. Bakalov, and V. B. Ho Growth Hormone Treatment and Aortic Dimensions in Turner Syndrome J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1785 - 1788. [Abstract] [Full Text] [PDF]

				J. E. Ostberg, A. E. Donald, J. P. J. Halcox, C. Storry, C. McCarthy, and G. S. Conway Vasculopathy in Turner Syndrome: Arterial Dilatation and Intimal Thickening without Endothelial Dysfunction J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5161 - 5166. [Abstract] [Full Text] [PDF]